logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (viii) All inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates24.253.770.773.366.659.746.637.6140141793
Cocaine4.17.48.58.710.410.69.24.11887391
Stimulants15.416.68.85.35.96.46.95.63313268
Hypnotics and sedatives3.32.63.55.510.017.729.045.51168317
Hallucinogens0.20.20.20.40.10.20.00.05420
Volatile substances3.01.50.40.50.80.20.00.034432
Cannabis 43.415.15.84.84.24.25.00.94091528
Other substances 6.43.02.01.42.01.03.46.3813364
Total418711754536522911025481262319256843713

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LU,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR. 

 Last data available from Poland refer to 2008. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011